Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein

References

• Zaki A, van Boheemen S, Bestebroer T, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. New Engl J Med. 2012;367:1814–1820. doi: 10.1056/NEJMoa1211721
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Middle East respiratory syndrome coronavirus (MERS-CoV) – [updated 2019 March; cited 2019 Sep 26]. Available from: http://www.who.int/emergencies/mers-cov/en/
   Google Scholar
• World Health Organisation (WHO). Middle East respiratory syndrome coronavirus (MERS-CoV): WHO MERS-CoV Global Summary and Assessment of Risk; 2018. Available from: https://www.who.int/csr/disease/coronavirus_infections/risk-assessment-august-2018.pdf
   Google Scholar
• Sabir JSM, Lam TT-Y, Ahmed MMM, et al. Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science. 2016;351:81–84. doi: 10.1126/science.aac8608
   PubMed Web of Science ®Google Scholar
• Mohd HA, Al-Tawfiq JA, Memish ZA. Middle East respiratory syndrome coronavirus (MERS-CoV) origin and animal reservoir. Virol J. 2016;13:87. doi: 10.1186/s12985-016-0544-0
   PubMed Web of Science ®Google Scholar
• Reusken CB, Schilp C, Raj VS, et al. MERS-CoV infection of alpaca in a region where MERS-CoV is endemic. Emerg Infect Dis. 2016;22:1129–1131. doi: 10.3201/eid2206.152113
   PubMed Web of Science ®Google Scholar
• David D, Rotenberg D, Khinich E, et al. Middle East respiratory syndrome coronavirus specific antibodies in naturally exposed Israeli llamas, alpacas and camels. One Health. 2018;5:65–68. doi: 10.1016/j.onehlt.2018.05.002
   PubMed Web of Science ®Google Scholar
• Crameri G, Durr PA, Klein R, et al. Experimental infection and response to rechallenge of alpacas with Middle East respiratory syndrome coronavirus. Emerg Infect Dis. 2016;22:1071–1074. doi: 10.3201/eid2206.160007
   PubMed Web of Science ®Google Scholar
• Adney DR, Bielefeldt-Ohmann H, Hartwig AE, et al. Infection, replication, and transmission of Middle East respiratory syndrome coronavirus in alpacas. Emerg Infect Dis. 2016;22:1031–1037. doi: 10.3201/eid2206.160192
   PubMed Web of Science ®Google Scholar
• Vergara-Alert J, van den Brand JMA, Widagdo W, et al. Livestock susceptibility to infection with Middle East respiratory syndrome coronavirus. Emerg Infect Dis. 2017;23:232–240. doi: 10.3201/eid2302.161239
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). WHO Target Product Profiles for MERS-CoV Vaccines, 2017. Available from: https://www.who.int/blueprint/what/research-development/MERS_CoV_TPP_15052017.pdf
   Google Scholar
• Aguanno R, ElIdrissi A, Elkholy AA, et al. MERS: Progress on the global response, remaining challenges and the way forward. Antiviral Res. 2018;159:35–44. doi: 10.1016/j.antiviral.2018.09.002
   PubMed Web of Science ®Google Scholar
• Raj VS, Mou H, Smits SL, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495:251–254. doi: 10.1038/nature12005
   PubMed Web of Science ®Google Scholar
• Okba NM, Raj VS, Haagmans BL. Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches. Curr Opin Virol. 2017;23:49–58. doi: 10.1016/j.coviro.2017.03.007
   PubMed Web of Science ®Google Scholar
• Cho H, Excler J-L, Kim JH, et al. Development of Middle East respiratory syndrome coronavirus vaccines – advances and challenges. Hum Vaccin Immunother. 2018;14:304–313. doi: 10.1080/21645515.2017.1389362
   PubMed Web of Science ®Google Scholar
• Stalin Raj V, Okba NMA, Gutierrez-Alvarez J, et al. Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection. Sci Adv. 2018;4:eaas9667. doi: 10.1126/sciadv.aas9667
   PubMed Web of Science ®Google Scholar
• Widjaja I, Wang C, van Haperen R, et al. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein. Emerg Microbes Infect. 2019;8:516–530. doi: 10.1080/22221751.2019.1597644
   PubMed Web of Science ®Google Scholar
• Xu J, Jia W, Wang P, et al. Antibodies and vaccines against Middle East respiratory syndrome coronavirus. Emerg Microbes Infect. 2019;8:841–856. doi: 10.1080/22221751.2019.1624482
   PubMed Web of Science ®Google Scholar
• Haagmans BL, van den Brand JMA, Raj VS, et al. An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels. Science. 2016;351:77–81. doi: 10.1126/science.aad1283
   PubMed Web of Science ®Google Scholar
• Guo X, Deng Y, Chen H, et al. Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus. Immunology. 2015;145:476–484. doi: 10.1111/imm.12462
   PubMed Web of Science ®Google Scholar
• Kim E, Okada K, Kenniston T, et al. Immunogenicity of an adenoviral-based Middle East respiratory syndrome coronavirus vaccine in BALB/c mice. Vaccine. 2014;32:5975–5982. doi: 10.1016/j.vaccine.2014.08.058
   PubMed Web of Science ®Google Scholar
• Cockrell AS, Yount BL, Scobey T, et al. A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nat Microbiol. 2017;2:16226. doi: 10.1038/nmicrobiol.2016.226
   Web of Science ®Google Scholar
• Hashem AM, et al. A highly immunogenic, protective and safe adenovirus-based vaccine expressing MERS-CoV S1-CD40L fusion protein in transgenic human DPP4 mouse model. J Infect Dis. 2019;pii:jiz137.
   Google Scholar
• Malczyk AH, Algaissi A, Agrawal A, et al. A Highly immunogenic and protective Middle East respiratory syndrome coronavirus vaccine based on a recombinant measles virus vaccine platform. J Virol. 2015;89:11654–11667. doi: 10.1128/JVI.01815-15
   PubMed Web of Science ®Google Scholar
• Wirblich C, Coleman CM, Kurup D, et al. One-Health: a safe, efficient, dual-use vaccine for humans and animals against Middle East respiratory syndrome coronavirus and rabies virus. J Virol. 2017;91:1–15. doi: 10.1128/JVI.02040-16
   Web of Science ®Google Scholar
• Zhao J, Li K, Wohlford-Lenane C, et al. Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci USA. 2014;111:4970–4975. doi: 10.1073/pnas.1323279111
   PubMed Web of Science ®Google Scholar
• Muthumani K, Falzarano D, Reuschel EL, et al. A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates. Sci Transl Med. 2015;7:301ra132. doi: 10.1126/scitranslmed.aac7462
   PubMed Web of Science ®Google Scholar
• Wang C, Zheng X, Gai W, et al. MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques. Oncotarget. 2017;8:12686–12694.
   PubMedGoogle Scholar
• Lan J, Yao Y, Deng Y, et al. Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge. EBioMedicine. 2015;2:1438–1446. doi: 10.1016/j.ebiom.2015.08.031
   PubMed Web of Science ®Google Scholar
• Zhang N, Channappanavar R, Ma C, et al. Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus. Cell Mol Immunol. 2016;13:180–190. doi: 10.1038/cmi.2015.03
   PubMed Web of Science ®Google Scholar
• Lan J, Deng Y, Chen H, et al. Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen. PLoS One. 2014;9:e112602. doi: 10.1371/journal.pone.0112602
   PubMed Web of Science ®Google Scholar
• Tang J, Zhang N, Tao X, et al. Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus. Hum Vaccin Immunother. 2015;11:1244–1250. doi: 10.1080/21645515.2015.1021527
   PubMed Web of Science ®Google Scholar
• Tai W, Wang Y, Fett CA, et al. Recombinant receptor-binding domains of multiple Middle East respiratory syndrome coronaviruses (MERS-CoVs) induce cross-neutralizing antibodies against divergent human and camel MERS-CoVs and antibody escape mutants. J Virol. 2017;91:e01651–16. doi: 10.1128/JVI.01651-16
   PubMed Web of Science ®Google Scholar
• Tao X, Garron T, Agrawal AS. Characterization and demonstration of the value of a lethal mouse model of Middle East respiratory syndrome coronavirus infection and disease. J Virol. 2016;90:57–67. doi: 10.1128/JVI.02009-15
   PubMed Web of Science ®Google Scholar
• Tai W, Zhao G, Sun S, et al. A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection. Virology. 2016;499:375–382. doi: 10.1016/j.virol.2016.10.005
   PubMed Web of Science ®Google Scholar
• Jiaming L, Yanfeng Y, Yao D, et al. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Vaccine. 2017;35:10–18. doi: 10.1016/j.vaccine.2016.11.064
   PubMed Web of Science ®Google Scholar
• Adney RD, Wang L, van Doremalen N, et al. Efficacy of an adjuvanted Middle East respiratory syndrome coronavirus spike protein vaccine in dromedary camels and alpacas. Viruses. 2019;11:212. doi: 10.3390/v11030212
   PubMed Web of Science ®Google Scholar
• Mou H, Raj VS, van Kuppeveld FJM, et al. The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. J Virol. 2013;87:9379–9383. doi: 10.1128/JVI.01277-13
   PubMed Web of Science ®Google Scholar
• Vergara-Alert J, Raj VS, Muñoz M, et al. Middle East respiratory syndrome coronavirus experimental transmission using a pig model. Transbound Emerg Dis. 2017;64:1342–1345. doi: 10.1111/tbed.12668
   PubMed Web of Science ®Google Scholar
• Corman VM, Eckerle I, Bleicker T, et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012;17:20285.
   PubMedGoogle Scholar
• Coleman CM, Frieman MB. Growth and quantification of MERS-CoV infection. Curr Protoc Microbiol. 2015;37(1):15E.2.1–15E.2.9. doi: 10.1002/9780471729259.mc15e02s37
   PubMedGoogle Scholar
• Okba NMA, Raj VS, Widjaja I, et al. Sensitive and specific detection of Low-level antibody responses in Mild Middle East respiratory syndrome coronavirus infections. Emerg Infect Dis. 2019;25:1868–1877. doi: 10.3201/eid2510.190051
   PubMed Web of Science ®Google Scholar
• Burbelo PD, Goldman R, Mattson TL. A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins. BMC Biotechnol. 2005;5:22. doi: 10.1186/1472-6750-5-22
   PubMed Web of Science ®Google Scholar
• Burbelo PD, Ching KH, Klimavicz CM, et al. Antibody profiling by luciferase immunoprecipitation systems (LIPS). J Vis Exp. 2009;32:1549.
   Google Scholar
• Li W, Hulswit RJG, Widjaja I, et al. Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein. Proc Natl Acad Sci. 2017;114:E8508–E8517. doi: 10.1073/pnas.1712592114
   PubMed Web of Science ®Google Scholar
• Letko M, Miazgowicz K, McMinn R, et al. Adaptive Evolution of MERS-CoV to species Variation in DPP4. Cell Rep. 2018;24:1730–1737. doi: 10.1016/j.celrep.2018.07.045
   PubMed Web of Science ®Google Scholar
• Hemida MG, Alnaeem A, Chu DK, et al. Longitudinal study of Middle East respiratory syndrome coronavirus infection in dromedary camel herds in Saudi Arabia, 2014–2015. Emerg Microbes Infect. 2017;6:1–7. doi: 10.1038/emi.2017.44
   PubMed Web of Science ®Google Scholar
• Ibrahim EE-S, Gamal WM, Hassan AI, et al. Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine. Vet World. 2015;8:1189–1198. doi: 10.14202/vetworld.2015.1189-1198
   PubMed Web of Science ®Google Scholar